|
Market Closed -
NSE India S.E.
06:05:09 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 10.66 INR | +1.91% |
|
+6.07% | -45.08% |
Business description: Nectar Lifesciences Limited

Number of employees: 111
Sales by Activity: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals Products | 16.69B | 15.24B | 16.85B | 16.7B | - |
Geographical breakdown of sales: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 11.81B | 8.45B | 11.46B | 11.72B | - |
Outside India | 7.45B | 9.01B | 7.79B | 7.37B | - |
Executive Committee: Nectar Lifesciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 2022-11-13 |
| Compliance Officer | - | 2025-03-31 |
Composition of the Board of Directors: Nectar Lifesciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 1995-06-26 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 2019-02-10 |
| Director/Board Member | 75 | 2021-09-20 | |
Indu Pal Kaur
BRD | Director/Board Member | 61 | 2022-08-01 |
Company details: Nectar Lifesciences Limited

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.91% | +6.07% | -27.73% | -58.36% | 21.96M | ||
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | ||
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | ||
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | ||
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | ||
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | ||
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | ||
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | ||
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | ||
| Average | +0.43% | +2.48% | +29.08% | +69.19% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.50% |
- Stock Market
- Stocks
- NECLIFE Stock
- Company Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions
















